Collplant Biotechnologies Ltd current report, Q4 FY2019

Business Context and Reporting Period

Company: CollPlant Biotechnologies Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: November 22, 2019
Context: The filing announces the convening of an Annual and Extraordinary General Meeting of Shareholders scheduled for December 31, 2019, in Tel-Aviv, Israel. The document serves to provide shareholders with the Notice and Proxy Statement, Proxy Card, and Voting Instruction Card.

Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a corporate governance notification regarding a shareholder meeting and does not contain financial statements or performance data.

Material Changes

No material financial changes versus a prior comparable period are reported in this document.

Guidance, Outlook, and Management Commentary

Shareholder Meeting Details:

  • Date: December 31, 2019
  • Time: 10:00 a.m. Israel time
  • Location: Gross, Kleinhendler, Hodak, Halevy, Greenberg, Shenhav & Co., One Azrieli Center, Round Building, 40th Floor, Tel-Aviv, Israel
Attached Documents:
  • Exhibit 99.1: Notice and Proxy Statement describing proposals and voting procedures.
  • Exhibit 99.2: Proxy Card for ordinary share holders.
  • Exhibit 99.3: Voting Instruction Card for ADS holders (via Bank of New York Mellon).
Risks and Contingencies: The filing text does not provide specific risk factors or contingencies beyond the standard incorporation by reference into Registration Statements on Form S-8 and Form F-3.

Key Facts for Investor Verification

  • Verify the specific proposals to be voted upon in the attached Notice and Proxy Statement (Exhibit 99.1).
  • Confirm the record date for shareholder eligibility, which is not explicitly stated in this summary text but is contained in the attached exhibits.
  • Review the voting procedures for both ordinary shares and ADS holders to ensure proper submission of proxies or voting instructions.
  • Note that this filing incorporates by reference into active Registration Statements (S-8 and F-3).